Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Clinical Genitourinary Cancer
|
December 5, 2017
Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy
Juan Morote, Inma Comas, Jacques Planas, et al.
Endocrine-Related Cancer
|
July 13, 2021
PARP inhibitors in advanced prostate cancer: when to use them?
Nely Díaz-Mejía, David García-Illescas, Rafael Morales-Barrera, et al.
International Journal of Environmental Research and Public Health
|
March 28, 2026
Sentinel Physicians for the Environment: A Chilean Perspective to Address Global Health and Climate Resilience
Paolo Lauriola, Jaime Sepúlveda Cisternas, Lisa De Pasquale, et al.
BJU International
|
May 9, 2013
Role of immunotherapy in castration-resistant prostate cancer (CRPC)
Cristina Suárez, Rafael Morales-Barrera, Victor Ramos, et al.
BMJ Case Reports
|
July 1, 2025
Combined neuroendocrine carcinoma of the penis: clinical, pathological and therapeutic insights
Lesly Cinthya Palomino Escobar, Nely Díaz-Mejía, Xavier Maldonado, et al.
BMJ Case Reports
|
February 12, 2026
Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma
Failah Mohamed Lamin Mohamed Mouloud, Rafael Morales-Barrera, Inés María de Torres, et al.
Cancer Treatment Reviews
|
March 24, 2020
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor
Rafael Morales-Barrera, Cristina Suárez, Macarena González, et al.
Cancer Treatment Reviews
|
October 16, 2016
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope
Rafael Morales-Barrera, Cristina Suárez, Ana Martínez de Castro, et al.
Expert Review of Molecular Diagnostics
|
September 5, 2020
Genetic testing for the clinician in prostate cancer
Fernando López-Campos, Estefanía Linares-Espinós, Xavier Maldonado Pijoan, et al.
Frontiers in Oncology
|
August 1, 2022
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
Pedro C Lara, Juan I Rodríguez-Melcón, Amalia Palacios-Eito, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Clinical Genitourinary Cancer
|
December 5, 2017
Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy
Juan Morote, Inma Comas, Jacques Planas, et al.
Endocrine-Related Cancer
|
July 13, 2021
PARP inhibitors in advanced prostate cancer: when to use them?
Nely Díaz-Mejía, David García-Illescas, Rafael Morales-Barrera, et al.
International Journal of Environmental Research and Public Health
|
March 28, 2026
Sentinel Physicians for the Environment: A Chilean Perspective to Address Global Health and Climate Resilience
Paolo Lauriola, Jaime Sepúlveda Cisternas, Lisa De Pasquale, et al.
BJU International
|
May 9, 2013
Role of immunotherapy in castration-resistant prostate cancer (CRPC)
Cristina Suárez, Rafael Morales-Barrera, Victor Ramos, et al.
BMJ Case Reports
|
July 1, 2025
Combined neuroendocrine carcinoma of the penis: clinical, pathological and therapeutic insights
Lesly Cinthya Palomino Escobar, Nely Díaz-Mejía, Xavier Maldonado, et al.
BMJ Case Reports
|
February 12, 2026
Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma
Failah Mohamed Lamin Mohamed Mouloud, Rafael Morales-Barrera, Inés María de Torres, et al.
Cancer Treatment Reviews
|
March 24, 2020
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor
Rafael Morales-Barrera, Cristina Suárez, Macarena González, et al.
Cancer Treatment Reviews
|
October 16, 2016
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope
Rafael Morales-Barrera, Cristina Suárez, Ana Martínez de Castro, et al.
Expert Review of Molecular Diagnostics
|
September 5, 2020
Genetic testing for the clinician in prostate cancer
Fernando López-Campos, Estefanía Linares-Espinós, Xavier Maldonado Pijoan, et al.
Frontiers in Oncology
|
August 1, 2022
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
Pedro C Lara, Juan I Rodríguez-Melcón, Amalia Palacios-Eito, et al.
Page
of 5